Company Overview and News

 
Gujarat Bitumen to hold board meeting

2016-08-05 indiainfoline
Diversified portfolio, pick-up in decorative and industrial paints (implementation of the Seventh Pay Commission) and decline in ...

 
Gabelli Multimedia Trust Reaffirms Its 10% Distribution Policy and Declares Second Quarter Distribution of $0.22 Per Share

2015-11-29 finance.yahoo
The Board of Directors of The Gabelli Multimedia Trust Inc. reaffirmed its 10% distribution policy and declared a $0.22 per share cash distribution payable on June 23, 2015 to common stock shareholders of record on June 16, 2015.

 
Gabelli Multimedia Trust Reaffirms Its 10% Distribution Policy and Declares First Quarter Distribution of $0.22 per Share

2015-11-29 finance.yahoo
The Board of Directors of The Gabelli Multimedia Trust Inc. reaffirmed its 10% distribution policy and declared a $0.22 per share cash distribution payable

 
Gabelli Multimedia Trust Reaffirms Its 10% Distribution Policy and Declares Third Quarter Distribution of $0.22 Per Share

2015-11-29 finance.yahoo
The Board of Directors of The Gabelli Multimedia Trust Inc. reaffirmed its 10% distribution policy and declared a $0.22 per share cash distribution payable on September 23, 2015 to common stock shareholders of record on September 16, 2015.

 
Gabelli Multimedia Trust Reaffirms Its 10% Distribution Policy and Declares Fourth Quarter Distribution of $0.28 Per Share

2015-11-29 finance.yahoo
The Board of Directors of The Gabelli Multimedia Trust Inc. reaffirmed and satisfied its 10% distribution policy by declaring a $0.28 per share cash distribution payable on December 18, 2015 to common stock shareholders of record on December 11, 2015.

 
Gabelli Healthcare & WellnessRx Trust Reaffirms Its Quarterly Distribution Policy and Declares Fourth Quarter Distribution of $0.13 Per Share

2015-11-29 finance.yahoo
The Board of Trustees of The Gabelli Healthcare & WellnessRx Trust reaffirms its quarterly distribution policy and declared a $0.13 per share cash distribution payable on December 18, 2015 to common shareholders of record on December 11, 2015.

 
Gabelli Utility Trust Continues Monthly Distributions, Declaring Distributions of $0.05 Per Share

2015-11-19 finance.yahoo
The Board of Trustees of The Gabelli Utility Trust approved the continuation of its policy of paying fixed monthly cash distributions. The Board of Trustees declared cash distributions of $0.05 per share for each of January, February, and March 2016.

 
UPDATE 1-U.S. funds optimistic about Allergan piled in before Pfizer bid

2015-11-19 reuters
Nov 19 Several large U.S. funds that boosted their stakes in Allergan Plc in recent months appear to be optimistic about the company's growth prospects, even before Pfizer's reported $150 billion takeover bid for the botox maker.

 
U.S. funds optimistic about Allergan piled in before Pfizer bid

2015-11-19 reuters
Nov 19 Several large U.S. funds that boosted their stakes in Allergan Plc in recent months appear to be optimistic about the company's growth prospects, even before Pfizer's reported $150 billion takeover bid for the botox maker.

 
A New Hidden Gem: The Acquisition Of Alteva, Inc.

2015-11-19 seekingalpha
The buyer will pay an amount of $4.70 a share in cash, which represents a 3.29% absolute return and 39.48% annualized return (it is said to close in mid-December). Some other sophisticated hedge funds

 
Time Warner win would make Murdoch U.S. media king

2015-11-17 in.finance.yahoo
Rupert Murdoch’s Twenty-First Century Fox Inc made an audacious offer for Time Warner Inc that if it succeeds would transform the American media landscape and cement the 83-year-old's status as the most powerful magnate in U.S. media and entertainment. While Time Warner, whose assets include the HBO cable channel and the Warner Bros movie studio, rejected the $80 billion bid, Murdoch is unlikely to abandon the pursuit and has the “disciplined determination” to get the deal done, people close to the situation said.

 
Time Warner win would make Murdoch U.S. media king

2015-11-17 in.finance.yahoo
REUTERS - (Paragraph 10 corrected to show AOL bought Time Warner in 2000, not visa versa) Rupert Murdoch’s Twenty-First Century Fox Inc made an audacious offer for Time Warner Inc that if it succeeds would transform the American media landscape and cement the 83-year-old's status as the most powerful magnate in U.S. media and entertainment. While Time Warner, whose assets include the HBO cable channel and the Warner Bros movie studio, rejected the $80 billion bid, Murdoch is unlikely to abandon the pursuit and has the “disciplined determination” to get the deal done, people close to the situation said.

 
GAMCO Investors' Upcoming Spin-Off To Unlock Significant Value

2015-11-10 seekingalpha
The upcoming spin-off could unlock significant value as the prior Teton Advisers 'financial engineering' move did since 2009 rising 1700%.The core long-only mutual funds continue to gain business grow

 
Dividend Challengers (And Near-Challengers): 73 Increases Expected By Year-End

2015-10-16 seekingalpha
2015 ends with two very busy months.Two dozen new challengers may be added.Plenty of double-digit increases Likely.

 
2015 shaping up to be a stock-pickers year

2015-10-12 seekingalpha
BAML's Savita Subramanian figures more than 41% of active managers are beating their benchmarks this year vs. only 19% who did so in 2014. At this pace, mutual funds are on track for their best relati

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...